SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-23-006532
Filing Date
2023-03-06
Accepted
2023-03-06 16:29:36
Documents
1
Period of Report
2023-03-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167813816425740.html 4  
1 FORM 4 wf-form4_167813816425740.xml 4 4008
  Complete submission text file 0001628280-23-006532.txt   5365
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Issuer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4520 EAST WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814
Business Address
Donley Matthew Maxwell (Reporting) CIK: 0001636642 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36421 | Film No.: 23709296